Juan-Giner A, Hitchings MD, Soumah A, Strecker T, Sadjo M, et al.
2020-06-01 • Vaccine
2020-06-01 • Vaccine
Background
As part of a Phase III trial with the Ebola vaccine rVSVΔG-ZEBOV-GP in Guinea, we invited frontline workers (FLWs) to participate in a sub-study to provide additional inf...
Henao-Restrepo AM, Camacho A, Longini I, Watson CH, Edmunds WJ, et al.
2017-02-01 • Lancet
2017-02-01 • Lancet
BACKGROUND rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested the ...
